What I do

The evidence behind a clinical or research decision is spread across the literature, guidelines, trial registries and regulatory documents. I bring it together and turn it into a clear answer you can act on.

Evidence review

What is known about your question, how certain it is, and what is still missing. I search systematically, check every claim against its primary source, and state gaps and limitations plainly. Reviews range from one focused question to a whole field, across clinical, preclinical and regulatory evidence, with meta-analysis where the data allow.

Four confocal images from Figure 20 of Jasna Jarc’s doctoral thesis, from overview to close-up, of astrocytes (white) carrying latexin (red) beside POMC neurons (green) in the arcuate nucleus of the mouse hypothalamus.
Astrocytes and appetite neurons

Latexin-carrying astrocytes in close contact with POMC neurons, which help control appetite.

Jarc, 2023 · Doctoral thesis, Medical University of Vienna
Fig. 20 · © Jasna Jarc

Clinical trials

For sponsors

A map of who is testing what, at which phase and where, drawn from ClinicalTrials.gov and the EU’s trial register (CTIS), alongside the treatments already authorised.

For patients

The trials they may qualify for and, where none fits, compassionate use (expanded access in the US) or off-label use, in Slovenia, the EU and beyond. Patients and their doctors decide which to pursue.

Study documents

Models, endpoints, dose selection and comparators: the evidence behind preclinical and clinical study decisions. Your clinical, statistical and regulatory specialists own the design; I draft and review the protocols, synopses, investigator’s brochures and briefing books that carry it, under EU regulation and ICH guidelines.

Panels e and f of Figure 6 from the astrocyte preprint: green fluorescent astrocytes in the arcuate nucleus of a mouse after virus-mediated removal of Mfn2, and electron micrographs of astrocyte mitochondria in a control and an Mfn2 knockout mouse.
A preclinical model

Astrocytes lacking Mfn2 (green) and their mitochondria under the electron microscope, in a mouse model with defined endpoints: food intake, weight and synaptic coverage.

Harkany et al. · Research Square, 2024
Preprint · Fig. 6e–f, rearranged · CC BY 4.0

Scientific writing

For researchers

Manuscripts, reviews, abstracts and responses to reviewers.

For patients

Plain-language summaries of the research on their condition, in English or Slovenian, for families and patient organisations too.

First page of the case report Management of Lennox-Gastaut Syndrome with a CBD/THC Isolate Combination, by Jonathan Grunfeld and Jasna Jarc, published in the International Journal of Clinical Studies & Medical Case Reports.
Case report

Management of Lennox-Gastaut Syndrome with a CBD/THC Isolate Combination.

Grunfeld & Jarc · Int J Clin Stud Med Case Rep, 2025
Creative Commons Attribution

Ways to work together

Evidence snapshot

Full evidence review

Project coordination

Add-ons

Second-opinion dossier · In-person support
Typical length of each package. Project coordination runs for several months, with a trial sweep each month.
  1. Evidence snapshot

    Length
    About 1 week
    You receive

    One question, one short report: an evidence review with a written opinion, a trial landscape for sponsors, the trials and access routes for one patient, or a summary for patients or specialists.

    For example

    A team asks “Is there preclinical support for target X in indication Y?”

    A family asks “Are there trials my child could join?”

  2. Full evidence review

    Length
    2–3 weeks
    You receive

    A full review, a one-page summary and a glossary, including a trial eligibility matrix and access routes where relevant.

  3. Project coordination

    Length
    Several months
    You receive

    A longer project with several strands, coordinated with treating teams, research centres and CROs.

    Trial sweeps and the eligibility matrix are repeated each month, since registries change weekly, alongside new evidence on open questions and regulatory updates.

Add-ons

Available with any package, either from the start or at any point during the work.

Second-opinion dossier

A written package for a referral or specialist centre. It follows the format the centre’s intake expects and is written in English or Slovenian.

In-person support

Support in person, at meetings where the evidence matters. We agree together on what that looks like.

This is not medical advice. Decisions about treatment stay with the patient and their doctors.

Jarc et al.

Independent evidence review and scientific consulting.

Portrait of Jasna Jarc

Jasna Jarc, PhD

Neuroscientist and independent scientific consultant.

LinkedIn